Skip to main content

Merck's Vaxneuvance lead departs to help develop rival vaccine at Affinivax

 Kara Bickham, M.D., has left Merck to take up the chief medical officer role at Affinivax. The appointment gives the person who led clinical development of Merck’s pneumococcal conjugate vaccine Vaxneuvance a starring role in a push to bring a rival jab to market. 

Merck hired Bickham in 2014. Over the following years, Bickham won a series of promotions, culminating in the title of executive director, vaccines clinical research and responsibility for clinical trials of 15-valent pneumococcal conjugate jab Vaxneuvance. With the FDA approving Vaxneuvance, a rival to Pfizer’s Prevnar 13, last month, Bickham has left Merck to take up a position at Affinivax.

Bickham will now oversee development of a 24-valent pneumococcal conjugate vaccine that could go on to challenge Vaxneuvance and Prevnar for a blockbuster market. Affinivax recently presented data from a phase 2 trial that compared its Astellas-partnered vaccine to Pfizer’s Prevnar 13 and successor Pneumovax 23. The data caught the eye of Bickham.

“I have carefully watched the advancement of the novel MAPS technology and am very impressed with the recent clinical data presented on Affinivax’s 24-valent pneumococcal vaccine,” Bickham said in a statement. 


The MAPS technology referred to by Bickham is a multiple antigen presenting system that uses a novel approach to the binding of polysaccharides to proteins. Affinivax sees the approach as a simpler way to develop and produce vaccines and expects it to provide broader immune protection than traditional systems.


Bickham arrives at Affinivax as it gears up for a key test of the system. With phase 2 data in hand, Affinivax and Astellas are now preparing to take the 24-valent pneumococcal conjugate vaccine ASP3772 into registrational clinical trials. The rest of Affinivax’s vaccine candidates, some of which are covered by a research collaboration with Astellas, are yet to reach the clinic. 


https://www.fiercebiotech.com/biotech/merck-s-vaxneuvance-lead-departs-to-help-develop-rival-vaccine


Labels:

Comments

Post a Comment

Popular posts from this blog

Can We Make A Vaccine Against Smoking?

  This segment sounds good but we need to be careful here or we end up where we started in 2021 vaccines becoming political. 
Post a Comment
Read more

L.A. County reports 1st case of more contagious coronavirus variant as region surpasses 1M infections Nexstar News

  Los Angeles County confirmed its first case of the new, more contagious coronavirus strain first reported in the United Kingdom, health officials said Saturday. Authorities also announced that the region has surpassed 1 million coronavirus cases. A man who recently spent time in L.A. County was found to have the virus variant. He has since traveled to Oregon and is currently isolating there. Although this is the first confirmed case of the U.K. variant in the county, public health officials believe that the strain is already spreading in the community.  “The presence of the U.K. variant in Los Angeles County is troubling, as our healthcare system is already severely strained with more than 7,500 people currently hospitalized,” Barbara Ferrer, L.A. County public health director, said in a news release Saturday. “Our community is bearing the brunt of the winter surge, experiencing huge numbers of cases, hospitalizations and deaths, five-times what we experienced over the summe...
Post a Comment
Read more

Texas governor bans vaccine passports from being required in state ABC News

  Thats Right States like Texas and Florida got the Vaccine Passport Conspiracy from Del Bigtree.  https://abc7.com/politics/texas-governor-bans-vaccine-passport-requirement-in-state/10491161/ AUSTIN, Texas -- Gov. Greg Abbott issued an executive order Tuesday morning prohibiting state agencies or political subdivisions in Texas from creating a "vaccine passport" requirement. Conversation has grown around  vaccine passports recently as an option that can be used for travel or even eating out . They are typically described as an app with a code that verifies if someone has been vaccinated or recently tested negative for COVID-19. They're already in use in Israel, and in development in parts of Europe. But Abbott shut that down as an option in the Lone Star State with Executive Order No. GA - 35 also prohibiting "organizations receiving public funds from requiring consumers to provide documentation of vaccine status in order to receive any service or enter any place....
Post a Comment
Read more